Nicotinamide relaxes vascular smooth muscle by inhibiting myosin light chain kinase-dependent signaling pathways: implications for anticancer efficacy.


Autoria(s): Hirst, David
Data(s)

2004

Identificador

http://pure.qub.ac.uk/portal/en/publications/nicotinamide-relaxes-vascular-smooth-muscle-by-inhibiting-myosin-light-chain-kinasedependent-signaling-pathways-implications-for-anticancer-efficacy(b9ea8986-2a96-40ff-b21d-7ae1e4a3fe53).html

http://www.scopus.com/inward/record.url?scp=9244250304&partnerID=8YFLogxK

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Hirst , D 2004 , ' Nicotinamide relaxes vascular smooth muscle by inhibiting myosin light chain kinase-dependent signaling pathways: implications for anticancer efficacy. ' Oncology Research - Anticancer drug design , vol 14(10) , no. 10 , pp. 483-489 .

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/1300/1306 #Cancer Research
Tipo

article